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ABSTRACT  
 
Squamous cell carcinomas (SCC) are caused by high levels of UVB (B fraction 
of the ultra violet ray) radiation on susceptible animal tissue. Factors that 
influence the ultra violet radiation (UV) level in different parts of the world are 
altitude, intensity and duration of sunlight, and thickness of the ozone layer. 
South Africa’s UV radiation levels are amongst the highest recorded in the world. 
 
The UVB energy enters the squamous cell and damages the DNA, which results 
in the uncontrolled proliferation of the squamous cells. Ultimately this 
proliferation of the squamous cells leads to the formation of a squamous cell 
carcinoma. The normal histology of the well-ordered squamous cell tissue 
changes from its regular pattern to one of disintegration as the carcinoma grows 
at the expense of the normal tissue. 
 
This clinical study examines the results of 75 feline patients with solar-induced 
SCC of the nasal planum treated with Cobalt 60 radiation. The cats were grouped 
clinically according to the severity of the SCC from 1-4, least to worst. The cats 
were sedated and their nasal planums irradiated on a recognised veterinary 
fractionated protocol of Monday/Wednesday/Friday. The clinical response was 
judged by the visual reduction in size and the diminishing aggressiveness of the 
tumour. This response determined the radiation dose and the number of 
treatments.  
 
 v
 The cats, age, sex, clinical appearance, number of treatments, radiation dose and 
survival period were recorded. A photographic record was kept of the patient’s 
progress before, during, and after treatment and the cats’ subsequent period of 
monitoring. Environmental compliance by the owners with respect to limiting 
exposure to solar radiation was also recorded. 
 
The cats were monitored for two years after the initial radiation treatment. The 
results were statistically analysed and showed that there was a correlation 
between the initial graded appearance of the nasal planum SCC and the period of 
survival. There was no statistically significant effect on survival of the 
independent variables of age, sex, and total radiation dose. However the clinical 
evidence was, that cats presenting with early nasal planum SCCs and treated with 
a low dose of radiation survived well. Those with more advanced lesions 
responded less favourably but enjoyed the palliation of pain that the radiation 
provided. 
 
This study has shown that mega-voltage radiation can play a most effective part 
in the treatment of actinic induced nasal planum squamous cell carcinoma. The 
challenge is to educate the owners and veterinarians to recognise the condition at 
an early stage and for veterinarians to have access to mega voltage radiation 
machines. 
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 LIST OF DEFINITIONS 
 
Nasal planum Hairless area surrounding the external nares consisting of                    
a thick layer of keratinised squamous cell tissue.  
 
Gy (Grays) A unit of measure of ionizing radiation. 
 
 MED Minimal Erythemal Dose, which is the amount of UVB 
light which will cause a fair skin to pinken.  
 
WHO World Health Organization. 
 
SCC Squamous cell carcinomas. 
 
UV Ultra violet radiation. 
 
UVA A fraction of the UV radiation 320 – 400 nm.   
 
UVB B fraction of the UV radiation 290 – 320 nm. 
. 
UVC C fraction of the UV radiation 200 – 290 nm. 
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CHAPTER TWO  
MATERIALS AND METHODS 
2.1   INTRODUCTION 
Practitioners referred domestic cats with solar-induced squamous cell carcinoma of 
the nasal planum for radiation treatment. This study is therefore one of 
convenience sampling. Although more than 90 cats were treated for squamous cell 
carcinoma during the period (1998-2001) only 75 met the criteria of regular check 
ups (visual or telephonic) for the two years post initial radiation treatment. Of the 
other 22 cats that were treated during this period, six were squamous cell 
carcinoma of head and pinnae, one was dead within six months of non-related 
disease, eight were treated palliatively and seven were untraceable.  
 
Human patients who are in remission from cancer for more than five years are 
considered to be disease free. There is no comparable remission time for animals. 
But if the lifespan of cats to humans is compared at a ratio of approximately 5:1, it 
seems reasonable to use a two-year survival period as a successful treatment, as the 
two-year survival period then approximates to a human survival rate of 10 years. 
 
The end point of the study was survival during this two-year period. All cats, male 
and female had been sterilized. The tumours were visually graded T1- T4 (least to 
worst), and there were at least 15 patients in each grade. The fractionated radiation 
dose of each patient varied according to the visual assessment of the response to 
the treatment. The fractionated radiation dose, the number of treatments and the 
total radiation dose were recorded. Digital photographs of each patient were taken 
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from 01/09/99 onward and stored. The instituting of environmental and 
behavioural change was strongly recommended. 
 
Each patient was monitored every two to three months either visually or 
telephonically and the efficacy of the treatment was assessed two years after the 
initial radiation treatment. The clinical outcome was judged on the length of 
survival of the patient. Because the nature of this study was based on clinical 
therapeutic evidence there was no control group. However two clients who decided 
not to have any treatment for their cat and let nature take its course allowed 
photographic monitoring of the cats. These photographs are included in the results. 
 
The results of this study were compared to the treatment modalities referred to in 
the introduction 1.8. 
 
2.2   THE INITIAL CONSULTATION WITH THE OWNER AND PATIENT 
The first consultation with the owner was an evaluation of the general condition of 
the cat together with a visual assessment of the nasal planum tumour. The owner 
was fully informed of the etiology of the disease, the proposed radiation treatment 
and the necessity of ensuring that the cat’s lifestyle be changed to that of a 
nocturnal animal to limit further UV exposure.  
 
It was recommended that during the day from 8am to 5pm the cat should be kept in 
a bright sunny room that had a film of special plastic on the windows that blocked 
out the UV radiation. The infrared and the visible light were not affected so the cat 
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had the warmth and brightness from the sun but no UV exposure. The cats usually 
adapted to this new lifestyle within three days. 
 
After this consultation (approximately 1 hour) the owners were able to make an 
informed decision on whether or not to proceed with radiation therapy and/or the 
environmental control. If the owners decided to have their cat treated they 
completed an "Informed Consent to Treatment" form, Appendix A. The owners did 
not have to agree to the environmental changes but were requested to inform me of 
their decision. This decision was recorded. 
 
2.3   VISUAL GRADING OF THE TUMOUR 
The patients were grouped according to the visual severity of the tumour. The 
tumours were given a grading of T1 - T4 using an adaptation of the World Health 
Organization (WHO) classification of tumors in domestic animals (1980). 
Although the size of the tumour was noted and recorded photographically the 
criteria for the grading of the tumour was judged on the depth of the tumour rather 
than the size. It should be noted that the depth depends on the type of tissue that is 
affected and not on an absolute measurement.  
Table 2.1  Tumour grading scheme used in this study.  
        Adaptation from World Health Organisation Classification of tumors in domestic  
        animals (1980). 
 
Tumour Grade Criteria 
T1 Small very superficial or exophytic lesion 1-3 mm diameter and 1 mm deep 
(Figure 2.1 T1) 
T2 Superficial lesions 3-5 mm diameter and 1-2 mm deep minimal invasion. 
(Figure 2.1 T2). 
T3 Lesions more than 5 mm diameter and 2-3 mm deep or invasion of 
subcutis (Figure 2.1 T3). 
T4 Lesions more than 8 mm diameter and > 3 mm deep invading nasal 
septum cartilage, aggressive and painful (Figure 2.1 T4). 
 32
The following pictures show the clinical appearance of the tumours graded T1-T4. 
Note in particular the lack of pigmentation of the nasal planum tumour area also 
the tiny, black superficial flecks on the nasal planum of Figure 2.1. grade T1. 
 
         
Grade T1    Grade T2 
        
Grade T3    Grade T4 
Key: The arrows point to the early lesions of T1 and T2. 
 
Figure 2.1  The visual grading of the different tumour levels.  
 
 
2.4   CLINICAL DATA  
The clinical data listed below was recorded for each cat (Appendix B)  
a)  Breed, sex and age.  
b)  History with regard to the squamous cell carcinoma. 
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c)  Visual clinical grading of squamous cell carcinoma was initially described and 
recorded. This was later supplemented by digital photographs, which were taken 
before, during and after treatment and during the two-year monitoring period. This 
data was used to visually record and evaluate the success of the treatment. 
 
The cases were not verified by histopathology as often within days of taking a 
biopsy, the tumour increases alarmingly in size and aggressiveness (personal 
observation).The owner’s participation with regard to environmental control was 
scored on an “honesty scale” (owner information) of 1-3 scale (least to best). 
 
2.5   HISTOLOGICAL EXAMINATION OF NASAL PLANUM TUMOURS 
In order to try and understand the histopathology of the disease various slides of 
the nasal planum were examined. The biopsy material was obtained from two 
sources; the normal pigmented nasal planum tissue was taken, with the owner’s 
permission, from a young cat that had to be euthanased. The slides from normal 
tissue have been used to illustrate section 1.6, (figures 1.3, page 10; 1.4, page 11 
and 1.5, page 12). Other biopsy tissues exhibiting the carcinoma in various stages 
of development were examined. Veterinarians in private practice who needed to 
establish the pathology of the lesion on their feline patients’ nasal planums had 
submitted these biopsy tissues. They were not biopsies of the cats in the study. 
They were then sectioned, mounted and stained. The standard laboratory staining 
methods were used. Slides were stained using hematoxylin and eosin (Bancroft and 
Gamble 2002). These slides were then examined and described in section 3.3. 
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Now to digress; in 1996, radiation therapy for veterinary patients was not available 
in Johannesburg. However the laboratory animal unit of the University of the 
Witwatersrand had a Cobalt60 Theraton 80 radiation machine used for research. In 
private practice there were many cases of feline nasal planum squamous cell 
carcinoma being treated with limited success The books, Managing the Veterinary 
Cancer Patient by Ogilvie and Moore (1996) and the Textbook of Veterinary 
Internal Medicine, eds Ettinger and Feldman (1995) gave some insight into the 
exciting practice of veterinary radiation therapy. 
 
 
Figure 2.2  Cobalt60 Theraton 80 radiation machine.  
 
Fortuitously, Ogilvie and Moore (1996) reported on a study by Theon et al. (1995) 
describing the treatment of feline nasal planum SCCs using ortho-voltage radiation 
therapy (10 x 4 Gys), which seemed to have encouraging results. As a consequence 
of this article and remembering the two adages ”do no harm” and “nothing 
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ventured nothing gained” the decision was made to treat feline patients exhibiting 
SCC of the nasal planum, with cobalt radiation. Being cautious it was decided to 
halve the radiation dose used by Theon et al. (1995) on the early tumours (T1 and 
T2) and to carefully monitor the visual effect of the radiation.  
 
Accordingly the fractionated radiation dose was between 2 – 4 Gy per session 
depending on the severity of the tumour. T1 and T2 were radiated with 2 Gy at 
each session,. T3 with 3 Gy per session and T4 started off with 4 Gy and was 
reduced to 3 Gy as the tumour responded to the treatment. The number of 
treatments depended on the clinical response of the lesion with regard to 
aggressiveness and size, the patients being individually assessed before each 
treatment.  
 
The fractionated radiation dose, the total radiation dose (Gy) and the number of 
treatments were recorded. From 01/09/99 the cats were photographed (Olympus 
C-2000Z) before, during treatment and at check-up visits (Crewe, 2004). The 
university subsidized the capital expense and the maintenance of the Theraton 
machine and that meant the cost of radiation per treatment was R75.00 exclusive 
of drugs. 
 
Unfortunately the cats’ overall general behaviour was not recorded before, during 
or after treatment. However the owners were delighted as their cats’ pain 
diminished, their general condition improved and their behaviour returned to that 
exhibited before the squamous cell carcinoma had become apparent. 
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2.6   PROCEDURE FOR RADIATION THERAPY 
Food was withheld from the patient for at least 8 hours prior to treatment, whilst 
water was freely available. A recognised fractionated radiation veterinary protocol 
treatment is a Monday, Wednesday and Friday schedule and this was the 
programme that was followed. The cat was sedated with "Domitor" (Medetomidine 
hydrochloride) at 0.05-0.1 ml/kg. The cat was then positioned on its back 
supported by sand bags under the Cobalt60 Theraton 80 radiation machine. The skin 
to source distance was 80 cms. The nasal planum area to be radiated was the 
clinical tumour volume (CTV) plus a margin of at least a 0.5 cm. The nasal planum 
was then irradiated. The sedative was afterwards reversed with "Antisedan" 
(Atipamizole hydrochloride) at 0.04-0.06 ml/kg. 
 
2.7   MONITORING OF THE PATIENTS AFTER TREATMENT 
After the completion of the treatment the cat was monitored for the tumour 
recurrence, monthly for the first two months and thereafter every three months. 
However, the owners were often unable to adhere to this time interval and 
telephonic assessment had to be made. This method was unreliable, as the owners 
were unable to “read” the lesion correctly. As a result of this the survival rate was 
found to be a more precise method of monitoring the outcome of the treatment. 
 
The survival time was defined as the period from the first radiation treatment to 
that of death. Cats dying of non-related disease during the two-year follow up 
period were included in this study of 75 cats. 
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The compliancy of the owner with regard to UV exposure control was scored on 
an ‘honesty basis’ of:  
1.   Did nothing  
2.   Tried  
3.  Successfully changed the cat to being a nocturnal animal. During the day, 
the cat was confined to a room that had a special plastic film placed on the 
windows that filtered out the UV radiation.  
 
2.8 STATISTICAL ANALYSIS  
The results for sex and age in relation to tumour grade were first tested separately to 
see if there was any relationship to tumour grade; sex using the Chi Square test, and 
age using the Kruskal Wallis test (Zar 1996). The mean total radiation and number of 
treatments were also analysed using the Kruskal Wallis test. These last two are 
dependent variables and one would expect them to be linked to tumour grade. 
 
Combined factors were then subjected to the Cox proportional hazard model (Cox and 
Oakes 1984). This test was chosen because it is not based on assumptions about the 
nature and shape of the hazard function and is essentially a non-parametric method of 
analysis. It does however have an assumption that there is a log-linear relationship 
between the independent variables and the underlying hazard function, in this case 
death. It allows the analysis of several risk factors on survival. Survival curves were 
calculated using the Kaplan Meier method. 
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CHAPTER THREE 
RESULTS  
3.1 INTRODUCTION 
The criterion for judging the efficacy of the treatment in this study was 
straightforward; two years after the initial radiation treatment, the patients had 
either survived or succumbed. It was not possible to run a control group of cats but 
the photos of two patients that were not treated, but tracked, are shown below.  
 
   
(a)   At presentation        (b)   Two months later    
 
Figure 3.1   The appearance at presentation and the lesion two months later,  
before euthanasia  
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(a)   At presentation        (b)   Two months later 
 
Figure 3.2:  The appearance at presentation and the lesion two months later 
before euthanasia  
 
 
These patients emphasise the rapid growth of the tumour once it is clinically 
visible. Both cats were monitored from the time of first presentation when they 
were graded as T3 to two months later when the cats were euthanased. Without 
treatment the tumour at stage 3 progressed very rapidly. 
 
The data retrieved for each cat in the study were age, sex, total radiation dose (Gy) 
and the survival rate measured at six monthly intervals up to twenty-four months 
(Table 3.1). The total population was 75 and this consisted of the four groupings 
with reference to the severity of the nasal planum tumour T1 (n=16 i.e. 21%), T2 
(n=15 i.e. 20%), T3 (n=24 i.e.32%) and T4 (n=20 i.e.27%) as summarised in Table 
3.1 page 42. 
 
During the two year period, twelve of the 75 cats died of non-related disease, four 
from group T1, four from group T2, one from group T3 and three from group T4 
see Table 3.1. It is interesting to note that of the cats that survived the two year 
period, up until 2004, only one cat from the T1 group had died from squamous cell 
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carcinoma after 44 months, one cat from the grade T2 group after 41 months and 
one from the grade T3 group at 33 months. The other surviving cats were either 
still alive or had died from non-related diseases. 
 
3.2   STATISTICAL ANALYSIS OF THE RADIATION TREATMENT 
It should be noted that statistically these are small sample sizes. The results were 
submitted to statistical analysis to establish whether the factors of age, sex and total 
radiation dose were significantly related to tumour grade. The analysis was started 
by testing for differences in sex using the Chi squared test. The differences of the 
age of the cat, the tumour levels, the total radiation dose and the tumour level were 
examined by using the Kruskal Wallace test with tied ranks (Zar 1996) as the data 
were not normally distributed. The total data set was analysised using Cox’s 
regression analysis. 
 
Table 3.1 shows the data collected for survival, age, sex, number of treatments, 
total number of Gy., number of re-treatments, (censored or complete) tumour 
grade, number of individual patient per grade, and the patients that died of non-
related diseases. divided into the four tumour level groups T1, T2, T3 and T4. 
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Table 3.1   Data collected in this study grouped into tumour levels 
T1, T2, T3 and T4 
 
Group T1 –Tumor 1 
 
Survival 
(mnths) 
Age 
(yrs) Sex No.treat Tot Gys 
Re-
treats Censored 
Tumour 
Grade 
Cat 
number N/R 
24 9 F 2 4 0 censored Tumour 1 1   
24 4 M 3 4 1 censored Tumour 1 2   
24 9 M 2 4 0 censored Tumour 1 3   
24 13 F 2 4 0 censored Tumour 1 4   
24 7 F 2 6 0 censored Tumour 1 5   
24 13 M 2 6 0 censored Tumour 1 6   
24 10 M 1 2 0 censored Tumour 1 7   
24 7 F 2 4 0 censored Tumour 1 8   
24 18 F 2 4 0 censored Tumour 1 9   
24 9 M 5 13 2 censored Tumour 1 10   
24 16 F 2 6 0 censored Tumour 1 11   
24 8 F 2 4 0 censored Tumour 1 12   
18 10 F 2 6 0 censored Tumour 1 13 N/R 
6 10 F 2 5 0 censored Tumour 1 14 N/R 
12 7 M 2 6 0 censored Tumour 1 15 N/R 
12 12 F 1 3 0 censored Tumour 1 16 N/R 
 
 
Group 2 – Tumour Grade 2 
 
Survival 
(mnths) 
Age 
(yrs) Sex No.treat Tot Gys 
Re-
treats Censored 
Tumour 
Grade 
Cat 
number N/R 
24 15 M 2 6 1 censored Tumour 2 1   
24 17 F 2 6 0 censored Tumour 2 2   
24 14 F 3 6 0 censored Tumour 2 3   
24 13 F 3 9 0 censored Tumour 2  4   
12 8 M 4 11 1 complete Tumour 2 5   
24 8 M 1 4 0 censored Tumour 2 6   
12 10 F 4 9 0 complete Tumour 2 7   
24 6 M 2 6 0 censored Tumour 2 8   
24 10 F 2 6 0 censored Tumour 2 9   
24 7 M 6 20 1 censored Tumour 2 10   
12 10 M 4 12 1 censored Tumour 2 11 N/R 
12 8 F 6 18 1 censored Tumour 2 12 N/R 
4 14 F 3 6 0 censored Tumour 2 13 N/R 
14 7 M 10 31 2 censored Tumour 2 14 N/R 
24 9 F 2 4 0 censored Tumour 2 15   
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Group 3 – Tumour Grade 3 
 
Survival 
(mnths) 
Age 
(yrs) Sex No.treat Tot Gys 
Re-
treats Censored 
Tumour 
Grade 
Cat 
number N/R 
24 10 F 3 8 0 censored Tumour 3 1   
24 12 M 5 24 1 censored Tumour 3 2   
24 8 F 5 10 1 censored Tumour 3 3   
24 8 M 3 9 0 censored Tumour 3 4   
6 18 F 5 10 1 complete Tumour 3 5   
4 14 F 5 23 1 complete Tumour 3 6   
11 7 M 4 8 0 complete Tumour 3 7   
5 8 F 6 15 1 complete Tumour 3 8   
3 14 F 2 4 0 complete Tumour 3 9   
24 13 F 8 19 1 censored Tumour 3 10   
17 8 F 11 29 3 complete Tumour 3 11   
9 12 M 5 15 0 complete Tumour 3 12   
17 7 F 11 29 1 complete Tumour 3 13   
8 11 F 4 8 0 complete Tumour 3 14   
24 9 M 5 14 1 censored Tumour 3 15   
14 7 F 7 14 1 complete Tumour 3 16   
7 9 F 7 21 1 complete Tumour 3 17   
12 9 F 6 23 0 complete Tumour 3  18   
24 8 F 4 12 0 censored Tumour 3 19   
12 10 M 5 15 0 censored Tumour 3 20 N/R 
12 12 M 15 35 1 complete Tumour 3 21   
12 10 F 9 20 2 complete Tumour 3 22   
24 13 F 6 18 0 censored Tumour 3 23   
24 12 F 9 25 1 censored Tumour 3 24   
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Group 4– Tumour Grade 4 
 
Survival 
(mnths) 
Age 
(yrs) Sex No.treat Tot Gys 
Re-
treats Censored 
Tumour 
Grade 
Cat 
number N/R 
4 19 M 12 38 1 complete Tumour 4  1   
5 16 F 6 18 0 complete Tumour 4  2   
14 13 F 6 18 0 complete Tumour 4  3   
6 11 F 5 10 0 complete Tumour 4  4   
18 13 F 15 38 1 complete Tumour 4  5   
15 15 M 8 26 2 complete Tumour 4  6   
19 11 M 9 27 1 complete Tumour 4  7   
6 13 M 6 15 0 complete Tumour 4  8   
11 14 F 11 37 3 complete Tumour 4  9   
12 8 M 11 34 2 complete Tumour 4  10   
2 15 M 4 12 0 complete Tumour 4  11   
4 13 M 15 61 0 complete Tumour 4  12   
2 7 F 6 23 0 complete Tumour 4  13   
6 17 M 12 39 0 complete  Tumour 4 14   
2 10 F 6 17 1 complete Tumour 4  15   
5 13 F 11 38 1 complete Tumour 4  16   
6 3 M 10 27 2 censored Tumour 4 17 N/R 
6 8 M 6 21 0 censored Tumour 4 18 N/R 
5 13 F 2 6 0 complete Tumour 4 19   
6 23 M 5 15 0 censored Tumour 4 20 N/R 
 
Key: S - survival, D- dead, No r - number of treatments, N/R-non-related disease  
Re-treats - number of repeat treatments. Cats were numbered individually within the groups. 
 
 
3.2.1   Male to female ratio at different tumour levels 
Overall there were more female cats (44) than males (31) presented. Equal 
numbers of cats could have been expected in each group.  
 
        Table 3.2  The distribution of male and female cats at the different                    
                          tumour grades.                            
 
 T1 T2 T3 T4 Total 
Male 6 7 7 11 31 
Female 10 8 17 9 44 
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When tested using the Chi-square test it was found there were no significant 
differences between groups and that the tumour grade is independent of sex 
(χ2 = 4.4922, v = 3, 0.25> P>0.10). 
 
3.2.2   Male to female ratio radiation dose  
                                                                                           
The mean number of Gys given was slightly higher for males (mean = 17.33 
                                  
Gys) than females (mean = 14.22 Gys). When compared using the Chi-
square test the results were not found to be significantly different, (χ2 = 
0.3183, 0.50<P<0.75). On the basis of these two results, the data from male 
and female cats were pooled for each tumour grade. 
 
3.2.3   Age and tumour levels. 
The ages of the 75 cats ranged from 3 to 23 years. The overall mean age was 
10.96 years + 3.7. The mean age was relatively constant in groups T1-T3 
(T1-10.1 years; T2-10.4 years; T3-10.4 years), but as expected was higher in 
the group T4 being 12.8 years. Surprisingly one cat in Group 4 was only 
three years old. When results were compared using the Kruskal Wallis test, 
differences were not significant (H = 2.952, χ20.05 = 7.815, v = 3,  0.25 >P< 
0.10).  
 
3.2.4   Mean total radiation dose Gys at different tumour levels 
The mean total radiation dose for each group was T1=5 Gy, T2=10 Gy, 
T3=17 Gy and T4=26 Gy. When results were compared using the Kruskal 
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Wallis test with paired ranks they were found to be highly significant (H = 
43.88, χ20.001 = 16.266, v = 3, P=0.001). 
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Figure 3.3   The mean total radiation dose (Gys) at the different tumour                            
                     levels 
 
Clinically this result would be expected, as a higher radiation dose would be 
required to eliminate a greater tumour volume (T4) than a smaller tumour 
volume (T1). 
 
3.2.5   Number of treatments 
One would expect that the cats with the smaller tumours would need fewer 
treatments than those with larger tumors. The mean number of treatments for 
each group is as follows: T1 - 2, T2 - 4, T3 - 6 and T4 - 9 treatments. When 
tested with one way Kruskal Wallis test with tied ranks these results were 
found to be significantly different (H=35.348, χ 2  = 16.2266, v = 3, P = 
0.001). 
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3.2.6   Survival analysis 
 
A Cox regression analysis was prepared with SAS for Windows (Version 9.1; 
SAS Institute Inc, Cary NC, USA) using the proportional hazards  procedure.  
The overall survival was calculated using all the dependent variables of 
age, sex, number of treatments, re-treatments, total Gy, tumour grade 
(Figure 3.4).  
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Figure 3.4   Survival function for mean values of all independent variables.  
 
Dependent Variable: survival Censoring var.: censored 
Chi² = 48.7749 df = 6 p = .00000   N = 75 
  Beta Std. Err. t-value Exp beta Wald St      P 
Age 0.011121 0.056203 0.19787 1.011183 0.03915 0.843148 
Sex -0.467905 0.384804 -1.21595 0.626313 1.47855 0.224011 
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No. Treat -0.068422 0.143820 -0.47575 0.933866 0.22634 0.634257 
Total Gys 0.022761 0.048874 0.46572 1.023022 0.21689 0.641422 
Retreats -0.065125 0.244784 -0.26605 0.936950 0.07078 0.790201 
Grade 1.452949 0.317201 4.58053 4.275707 20.98126 0.000005 
 
 
 
The results showed a highly statistically significant effect of tumour grade on cat 
survival (P < 0.0000), but no significant effect for the other independent variables. 
 
Maximum likelihood estimates for tumour pre-treatment group indicator, sex and 
age (explanatory variables) can be seen in Table 3.3 
 
 Table 3.3   Analysis of maximum likelihood estimates 
 Parameter Standard Hazard 
Variable DF Estimate Error Chi-
Square 
Pr>Chi 
Square 
Ratio 
Tumour 1 0.80682 0.19224 17.6137 <.0001 2.241 
Age 1 0.04849 0.05623 0.7435 0.3886 1.050 
Sex 1 0.11872 0.34336 0.1196 0.7295 1.126 
 
The tumour was considered here as a continuous variable and further analysis 
with separated tumour groups showed that the differences between tumour 
groups were highly significant. The results for T4 were used as the baseline for 
the calculations. See Table 3.4. Although T1 (H (1)) and T2 (H (2) differed 
significantly from T4 they did not vary substantially from each other. The 
results were combined to produce the graph below (Figure 3.5). 
Table 3.4   Cox (proportional hazards) regression  
Deviance (likelihood ratio) chi-square = 7.554558   df = 4   P = 0.1093 
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H (1) b1  = -2.041194 z = -3.829192 P = 0.0001 
H (2) b2  = -2.61781 z = -3.433797 P = 0.0006 
H (3)  b3  = -1.054874 z = -2.778781 P = 0.0055 
H (4)  b4  = 0 z = * P < 0.0001 
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Figure 3.5  Survival  graph using Cox regression combining the results of T1 
and T2 (red)  and T3 and T4 (black)  showing the survival probability of the 
individual together with the tumour levels 
 
 
A simple Kaplan Meier analysis also showed that tumour grade at 
presentation had a highly statistically significant effect on survival 
(P<0.00001)
 
as illustrated by the al graphs below (See Figure 3.6). Deaths 
among T1 and T2 cats were from non related causes.  
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Figure 3.6  Kaplan –Meier survival graph for cats at the different tumour 
levels and the median values for T3 and T4. 
 
 
3.3  THE LONG-TERM FOLLOW UP OF CATS THAT SURVIVED THE 24- 
          MONTH STUDY  
 
Although the results of this study were based on a twenty-four month survival 
period, the surviving cats were tracked until November 2004 and, for interest and 
for the sake of completion, these results are recorded in Table 3.4. Because 
environmental control was not followed by most owners it was not possible to 
know if the recurrence of the tumour was due to insufficient initial radiation of the 
tumours or if they were newly acquired squamous cell carcinomas. 
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Table 3.5  Additional information on cats that survived longer than 24  
                  months  
 
T1         
Cat No Alive Dead SCC Dead N/R Comments 
 (Months) (Months) (Months)  
1   25   
 2 71   
Re-treated  (3X2Gys) after 52m.  
Compliancy scored 3 
3   45   
4   55   
5 63   Recurred after 29m re-treated 
6 72     
7  44    
8   25  Compliancy scored two 
9   45   
10 27   Re-treated (3X3Gys) cannot trace 
11     37   
 
T2     
Cat no Alive Dead SCC Dead N/R Comments 
 (Months) (Months) (Months)  
1   36 Compliancy scored two  
2 52   Re-treated after 41 months 
3   61   
4 33   Cannot trace after 01/02 
6  41    
8 51     
9 51     
10     37   
 
T3     
Cat no Alive Dead SCC Dead N/R Comments 
 (Months) (Months) (Months)  
1   81   
2  26    
3   61   
4   54   
10  33    
19 43       
 
Key: N/R- death due to non-related causes. Cat no - the individual cats recorded.  
Alive - living x months after first radiation treatment. Com - compliancy. Grade T1 number 2*- 
compliancy score of three (cat is still alive aged 11years, seven years after first treatment) 
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Two cats could not be traced, T1 (No 10) after 27 months and T2 (No 4) after 33 
months. Only one cat in Grade T1 died of squamous cell carcinoma, 44 months 
after treatment. In the Grade T2 group one cat died of squamous cell carcinoma, 41 
months after treatment. In the T3 group of the six that survived the 24-month 
period, one was alive after 43 months, two succumbed to squamous cell carcinoma 
and three died from non-related diseases. None of the cats in T4 group survived the 
24 months post radiation period and all died due to squamous cell carcinoma of the 
nasal planum. 
 
3.4  HISTOLOGICAL CHANGES OF THE NASAL PLANUM TISSUE  
        DURING THE COURSE OF THE DISEASE 
 
In examining the slides of normal tissue of the nasal planum, it was found to be 
unique. Although visually the nasal planum appears to be thick skin, histologically 
it seems to fall between the thick epidermis of the pads of the paws and the thin 
epidermis of the body. Thick epidermis has five strata: cornium, lucidum, 
granulosum, spinosum and basale whilst thin epidermis has three strata: corneum, 
spinosum and basale. The nasal planum tissue has three strata: cornium, spinosum 
and basale and although these layers are those of thin skin, the depth of the 
spinosum reflects that of the thick epidermis. The histology of the normal healthy 
tissue has been described in Section 1.6 (page 9) of this study. 
 
The sectioned and stained biopsy material the origin of which was recorded in 
Section 2.5 on page 34, is now examined and the histology described.  
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3.4.1 The histopathology of an early well-differentiated squamous cell   
         carcinoma  
The section (Figure 3.7) shows an early well-differentiated tumour of the 
non-pigmented nasal planum. There is hyperkeratosis and crust formation in 
the horny layer and early dysplastic changes in the basal cells of the 
epidermis. Note that there is no melanin in the basal cells. Trabeculae of 
neoplastic cells are starting to infiltrate into the dermis. The sebaceous 
glands are clearly visible. The glands appear to be stimulated in the early 
stages of the disease, the waxy exudate traps dust and fine dirt and often the 
first warning sign of pre-cancerous tissue is the observant owner recognising 
this symptom (see Figure 2.1 on page 33). 
 
Key: HK of HL - hyperkeratosis of the horny layer, NBM- normal basement membrane, 
T1 BMt - tumour showing dysplasia of the basement membrane (the start of SCC)with trabeculae of 
neoplastic cells ifitrating the dermis, SEB G - sebaceous gland 
 
Figure 3.7  Well-differentiated squamous cell carcinoma (X 40) 
 
HK of HL 
NBM 
T1BMt 
BBBM
T 
SEB G 
 54 
The following section (Figure 3.8) is also of an early well-differentiated 
tumour and is at a higher magnification than that of (Figure 3.7). It shows the 
strands of hyperkeratosis, the disturbance of the basement membrane and the 
infiltrating trabecula of the sqaumous cell carcinoma. 
 
Key: HK of HL - Hyperkeratosis of the horny layer, NBM - normal basement membrane, 
T1 BMt - tumour showing dysplasia of the basement membrane and infiltrating trabecula. 
 
Figure 3.8  Well-differentiated squamous cell carcinoma (X 400) 
 
Clinically the nasal planum would have the appearance of a T1 tumour that 
is shown in the text as Figure 2.1 on page 33. 
 
3.4.2 The histopathology of the intermediate (T2 and T3) squamous cell  
carcinoma 
 
Two typical sections of an intermediate infiltrating squamous cell carcinoma 
(Figure 3.9 on page 55 and Figure 3.10 on page 56) are shown arising from a 
carcinoma of the epidermis. There is neo-vascularisation and early keratin 
NBM 
T1BMt 
BMt 
HK of HL 
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pearl formation in addition to those changes already shown in Figure 3.7 and 
Figure 3.8. It is interesting to note that the sebaceous glands can still be 
distinguished in Figure 3.9 but not in Figure 3.10 and that the hyperkeratosis 
has disappeared in Figure 3.9 and is greatly diminished in Figure 3.10.  
 
 Key: BV - blood vessels, KP - keratin pearls, HK of HL- hyperkeratosis of the horny layer 
(greatly diminished), T2 SCC - Grade T2 squamous cell carcinoma 
 
Figure 3.9  Intermediate squamous cell carcinoma (X 100) 
 
 
Clinically these tumours are painful and tend to bleed easily when bumped, 
when the cat eats or grooms itself. This happens because the protective 
squamous layer is either no longer present or greatly diminished in thickness 
and there is an abundance of blood vessels in and around the tumour tissue. 
T2 SCC 
SEB G KP 
BV 
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Key: BV - blood vessels, KP - keratin pearls, TRAB of NC - trabeculae of neoplastic cells, HK of 
HL - hyperkeratosis of the horny layer (greatly diminished) 
 
Figure 3.10    Intermediate squamous cell carcinoma, (X 100) 
 
3.4.3   The poorly-differentiated (T3 and T4) squamous cell carcinomas 
The following sections in Figure 3.11, Figure 3.12 and Figure 3.13 show the 
extreme damage that is caused to the integrity of the epidermis, dermis and 
cartilage of the nasal turbinates by the squamous cell carcinoma. Usually the 
healthy unbroken junction between the cartilage and the dermis is clinically 
easy to appreciate when visually grading tumours (Figure 2.1 on page 33). 
However, when this junction is disturbed the nasal turbinates become visible 
and resulting carcinoma will be graded a T4 (Figure 2.1). 
 
HK of HL 
TRAB of NC 
KP 
BV 
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Figure 3.11  Poorly-differentiated squamous cell carcinoma, (X 40). 
 
In Figure 3.11  there is a deep ulcer through the epidermis and the dermis 
with resulting inflammation and crust formation. Around the ulcer there is 
some degree of hyperkeratosis of the horny layer visible. The sub-epithelial 
tissue contains numerous proliferating cords and nests of malignant 
neoplastic cells originating from the overlying epithelium. A few indistinct 
attempts at keratin pearl formation are seen and the basement membrane has 
been breached. No sebaceous glands are visible.  
 
When examining this section it becomes obvious why the area from which 
the biopsy is taken is would influence the histological grading of the 
squamous cell tumour.  
ULCER 
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Key: BV - blood vessels, TRAB of NC - trabeculae of neoplastic cells  
 
Figure 3.12  Poorly-differentiated squamous cell carcinoma (X 100) 
 
The neoplastic tissue is highly invasive. Numerous blood vessels can be seen 
together with trabeculae of neoplastic cells penetrating the dermis. 
BV 
TRAB of NC 
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Key: T4 SCC - Poorly-differentiated squamous cell carcinoma, RBC – erythrocytes 
 
Figure 3.13  Poorly differentiated squamous cell carcinoma (X 40).         
 
 
This section shows the poorly differentiated tumour (Grade T4) invading the 
nasal cartilage. The basement membrane has been breached and the tumour 
has spread from the epidermis, to the dermis and is invading the cartilage. 
The normal architecture of the junction between the dermis and the cartilage 
as seen in (Figure 1.5 on page 12) has been destroyed by the tumour. 
 
3.5   VISUAL RESULTS OF ONE PATIENT FROM EACH GRADE  
The following photographs are part of the treatment record. This record keeping 
makes it easy to show the client the result of the treatment. The pictures are printed 
in colour and given to the client. This allows the client to continually monitor his or 
her cat and be aware if tumour re-growth occurs. 
CARTILAGE 
RBC 
T4 SCC 
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(a)  at presentation                                                 (b)  twenty-four months later    
The arrow shows the black flecks on the nasal planum 
 
Figure 3.14:  Grade T1. The appearance at presentation and the lesion twenty-
four months later   
 
 
 
    
(a)  at presentation                                                 (b) twenty-four months later    
 
Figure 3.15:  Grade T2 The appearance at presentation and the lesion twenty-four 
months later   
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(a)  at presentation                                                       (b)  twenty-four months later    
 
Figure 3.16:  Grade T3 The appearance at presentation and the lesion twenty-four 
months later   
 
 
 
 
(a)  at presentation                                                    (b) twenty-four months later there were no        
                                                                                      survivors   
 
Figure 3.17  Grade T4 The appearance at presentation,  
 
3.6   SIDE EFFECTS OF RADIATION ON THE NASAL PLANUM 
There was no evidence of erythema, dry desquamation, pruritus or necrosis. 
Localised hair loss occurred in a few of the Grade 4 cases but the hair regrew after 
about six weeks. The late side effects of retinal degeneration and cataract formation 
were not observed at any time.  
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3.7  THE COST OF THE TREATMENT ACCORDING TO THE GRADE OF THE  
         TUMOUR 
 
The cost of radiation per treatment at the University during this study (1999-2002) 
was R75.00, This included the veterinary fee together with the cost of  the 
anaesthetic. It is interesting to note that currently in a private facility the cost is 
R385.00 per treatment.  
 
Table 3.6   Number and cost of treatments/grade  
Tumour 
Grade 
Number of 
treatments 
Cost (1999-2002) 
University 
Current cost at 
private facility 
1 3 (3X2Gy) R225.00 R1155.00 
2 4 (4X2Gy) R300.00 R1542.00 
3 5 (5X3Gy) R375.00 R1920.00 
4 9 (9X3Gy) R625.00 R3465.00 
 
3.8   THE VIABILITY OF ENVIRONMENTAL CONTROL 
The owners were advised to limit their cat’s exposure to solar radiation at the initial 
consultation and reminded of this important aspect regularly. However it was 
apparent during the monitoring of the study that very few owners followed the 
recommendation.  
 
On the ‘honesty scale’1-3 (least to best), (pages 50 and 54), only two of the 75 
owners scored two, and one owner scored a three. No statistical analysis is possible 
with such low numbers but for the sake of completion the three cats were tracked. 
Interestingly, of the two owners who ‘tried’ (score two on the scale 1-3) to control 
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their cats exposure to UVB, cat (Grade T1 No. 8) lived for 25 months and died of a 
non-related cause and cat (Grade T2 No. 1) lived for 36 months and died of a non-
related cause. The one owner who did score three has a cat that is now eleven years 
old, seven years after the initial radiation treatment.  
 
 
CHAPTER FOUR 
DISCUSSION 
 
4.1    INTRODUCTION 
Radiation treatment of the squamous cell carcinoma tumour of the nasal planum 
is dependent on the tumour cells’ response to the radiation. The UVB rays’ 
damage to the DNA of the basement membrane cell has been discussed in 
Chapter One. However it is not known how long it takes before the tumour can 
be seen clinically. It appears that the condition may develop slowly over months, 
or even years, but at a certain point the rate of tumour growth becomes 
exponential. This time is dependent on the cell cycle of the proliferating cells, the 
fraction of the total tumour cell population that is dividing and the degree of cell 
loss from the tumour (LaTorre Travis, 1989). Pictures of the two cats (Figure 3.1 
and Figure 3.2 on pages 39 and 40) that did not receive any treatment show how 
fast this exponential growth can be.  
 
Histological examination is an effective method of confirming the presence of the 
squamous cell carcinoma tumour. However taking a biopsy for grading a tumour has 
certain drawbacks, these difficulties include the following: the area of the tumour from 
which the biopsy has been taken, the fact that the tumour would flare up aggressively 
after the biopsy was taken, the extra expense to the owner and most importantly the 
unnecessary discomfort to the cat.  
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Environmental control was practical and possible but it was difficult to convince 
owners of the benefit, whilst the cost of the radiation therapy was so inexpensive at the 
subsidised university rate. The fact that the owners were not convinced during this 
study to limit their cats’ exposure to UVB was disappointing, even though as time 
went by it was evident that the cats could adjust to the environmental control. The new 
clients were shown pictures of patients that had been environmentally controlled, in 
comparison to those that had not and this has led to an increase in the environmental 
control on the part of the owners, resulting in this aspect of the treatment improving. 
The fact that radiation treatment is now considerably more expensive is an added 
inducement for environmental control. 
 
4.2   COMPARISON TO OTHER STUDIES 
The aim of every cancer therapy is to permanently remove all the cancer and pre-
cancerous cells. However, direct comparison of the previous studies is difficult 
because of the wide range of treatments, the lack of grading of the subjects and 
the different defined end points, Clarke (1991), Peaston et al. (1993) and Theon 
et al. (1995) reported the same difficulty in comparing their work to other studies. 
However, if no comparison is made, then this study joins most of the other 
studies in coming to no definite conclusion as to the value of the treatment. It also 
leaves the veterinarian in practice unable to guide his/her client in the choice of 
treatments available.  
 
In general, the results of this study compared satisfactorily to the six different 
therapies (surgery, cryotherapy, hyperthermia, photodynamic therapy, 
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chemotherapy and various radiation therapies) reviewed in this study in terms of 
survival. Although this study can only be directly compared to the visually 
graded studies of Theon et al. (1995) and Magne et al. (1997) the other forms of 
grading, treatment and results are included for completeness.  
 
4.2.1   Grading of the tumours  
Table 1.2 (page 26) summarises the form of therapy, the number of cats in 
the study and whether or not the cats’ tumours were graded. 
a) No grading. 
Seven of the fifteen studies in Table 1.2 did not record any grading: 
Atwater et al. (1991), Clarke (1991), Orenberg (1992), Roberts et al. 
(1991) and Lana et al. (1997) (Lana’s study covered surgical, cryotherapy 
and radiation therapy). On a survival judgment with non-graded tumours, 
the range of the results for surgery, cryotherapy and cobalt radiation 
treatment was large. 
b) Histological grading. 
Three studies were graded into well or poorly differentiated tumours 
Bostock et al. (1972), Withrow and Straw (1990) and Peaston et al. (1993). 
Theon et al. (1995) graded histologically into three groups. Three studies 
dealt with only the well-differentiated tumours: Grier et al. (1980), Evans 
et al. (1985) and Van Vechten (1993).  
c) Visual grading. 
The clinical visual appearance of the nasal planum tumour is very important as 
this is when the owner and the clinician first become aware of the tumour. The 
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greater the destruction of the normal configuration of the nasal planum, the 
higher the grading. An adaptation from The World Health Organisation (WHO) 
(Table 2.2 on page 32) was used to grade the patients. Magne et al. (1997) 
grouped the patients into three, on size and invasiveness of the tumour. Theon et 
al. (1995) grouped into four (Note that Theon also graded histologically into 
three groups).This present study grouped the cats into four grades. Experience 
from the present study found that use of four grades was both practical and 
satisfactory. 
 
Table 4.1.  Visual grading of three studies; percentage of each grade at  
                    presentation 
 
Study Total 
no of 
cats 
T1
% 
T2
% 
T3
% 
T4
% 
Magne et 
al. (1997) 
61 (T1a) 
25% 
 (T1b) 
30% 
(T2) 
45% 
Theon et 
al. (1995) 
90 17% 31% 37% 27% 
Crewe 
(2008) 
75 21% 20% 32% 27% 
 
 
 
Although Magne et al. (1997) graded the nasal planum lesions into three 
grades, both T1b and T2 were described as invasive. With these three 
studies the early presentation T1 was the lowest number (except for T2 in 
the present study) indicating that the owners only became aware of the 
disease in the later stages.. This is a problem as all the treatment modalities 
that have been discussed are more effect at the early stage of the disease. 
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The two visually graded studies that this study tries to compare results to 
are Theon et al. (1995) and Magne et al. (1997). They had subtly different 
end points; Theon et al. (1995) study had a progression-free survival time 
period (the interval between completion of irradiation and measurable 
tumour growth or death) and Magne et al. (1997) had a disease-free period. 
Despite these different end points, the results of these studies at twelve 
months was comparable (see Table 1.4 on page 27) where Theon et al. 
(1995) showed T1 was 84%  and Magne et al. (1997) (see Table 1.6 page 
28) where T1a was 100%. In the present study survival of twelve months, 
for T1 was 100% (excluding one death from non-related disease at six 
months) so that these three studies show good correlation on treatment of 
early stages the nasal  carcinomas. 
 
4.2.2 Endpoints of graded studies measured in months  
Some studies defined their endpoint as survival; others used progression-
free survival time, reduction in the size of the tumour and disease free 
period. Ten of the fifteen studies referred to in Table 1.6 on page 28 used 
the ‘disease free period’ as the end point for their study, making this the 
most accepted endpoint in this series of therapies. Several of the 
investigators noted that they did not manage to visually monitor their 
patients throughout the study period making the study difficult to complete. 
It should be emphasised that except for straightforward survival all the end 
points in this series of studies (progression-free survival time, reduction in 
the size of the tumour and disease free period) are open to human 
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interpretation of the lesion. The finality of death reduces these difficulties 
of interpretation. In this present study the criteria was simply, overall 
survival during a twenty-four month period.  
 
Comparing the current results to these two studies it appears that the visual 
grading of the patients was reasonably consistent and could possibly be 
more standardised in the future. 
 
4.2.3 Different modalities of treatment   
a) Surgery  
The first two studies concluded that this modality was only suitable for well-
differentiated tumours. Bostock (1972) reported in his study that the well-
differentiated cases had a median survival time of 11 months and the poorly 
differentiated tumours only a four month median survival time. The result of the 
Withrow and Straw (1990) study of nine cats showed that six cats were clinically 
free with a mean of 18 months (range 8-27 months) and local recurrence 
occurred in three cats with advanced poorly differentiated lesions at one, two and 
five months.  
 
Lana et al. (1997) reported on 21 cases but without reference to grading and 
found the disease-free interval to be a median of 60 months. The Lana et al. 
(1997) study appears to be more successful than the first two studies that have 
similar results but as the patients were not graded it is difficult to compare. When 
the results are compared for the early stages of the disease, the present study at 
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two years gives a survival rate of 100% for T1 and 87% for T2 (excluding those 
patients that died from non-related causes). This appears to be a better result than 
those results in the Bostock (1972) and Withrow and Straw (1990) studies at the 
early stages of the disease. However for the more advanced stages, the studies of 
Bostock (1972), Withrow and Straw (1990) and this study showed similar 
results.  
This surgical option is both very invasive and disfiguring and does not 
appear to give better results than radiation as applied in this study. The surgery 
option in South Africa would cost approximately R3500.00 and therefore the 
radiation treatment is less expensive and not painful. 
b) Cryotherapy 
None of the three studies Clarke (1991), Atwater et al. (1991) and Lana et 
al. (1997) graded their patients. All three reported a high recurrence of the 
disease and multiple treatments to give any long term control. Although 
liquid nitrogen is easily available to practices in South Africa this therapy 
does not have much of a following due to the early recurrence of the 
disease. Figure 4.1 shows a cat (a) after two treatments during a seven 
month period and (b) after radiation treatment.  
 
In South Africa each treatment would cost approximately R1500.00. 
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a)  at presentation                                                  b)  after radiation treatment 
 
Figure 4.1: (a) Cat after cryotherapy and (b) subsequent radiation therapy  
 
c) Hyperthermia 
This technique is difficult and complex. In the study by Greir et al. (1980) 
the cats were graded with superficial (well-differentiated) lesions. 
Complete remission was for only two to six months in 68% of the patients. 
Due to the technical difficulties and the poor results this therapy is not 
being used in South Africa. 
d) Photodynamic therapy
In the three studies, Roberts et al. (1991), Peaston et al. (1993) and Magne et al. 
(1997) similar results to cryotherapy were again shown, re-emphasizing the 
benefits of early treatment. Although all the patients in the study by Magne et al. 
(1997) were histologically confirmed as squamous cell carcinoma, they were also 
visually graded. The visually graded results gave a similar result to this study, for 
the grading T1a at 12 months being 100% but only 50% for T1b. The other more 
advanced grades responded poorly. Complete response rates as well as local 
control were significantly (<P0.05) related to the severity of the tumour which 
corresponds well with this study.  
e) Chemotherapy 
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There were two studies in this group. Evans et al. (1985) used cis-retinoic 
acid in a trial using cats with pre-neoplastic tumours. No reversal of the 
pre-neoplastic changes occurred. Orenberg et al. (1992) as recorded in 
Table 1.2 on page 26 and Table 1.5 on page 28 treated one hundred and 
eighteen cats with a cisplatin collagen-matrix intralesional implant and 
recorded that 83% of cats had a greater than 50% reduction in tumour size 
and 64% had complete resolution after six treatments. This treatment is 
used in South Africa but no recorded trials have been completed here. The 
cases that have been referred for radiation therapy are those that have not 
responded and radiation treatment has been requested. The cost for this 
kind of chemotherapy is between R1000.00-R1500.00 per treatment and 
usually four to six treatments are given, with a total cost of R4000.00-
R6000.00. 
 
     
a)  at presentation                                              b)  after radiation treatment 
 
Figure 4.2: (a) Cat after chemotherapy and (b) subsequent radiation therapy  
 
f) Radiation
(i)   Ortho voltage radiation
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Theon et al. (1995) used ortho-voltage radiation in a study of ninety cats visually 
graded T1-T4. Each patient received a total dose of 40 Gy in 4 Gy fractions. In the 
present study the radiation dose varied with the different tumour grades; for T1 the 
mean was 5 Gy, T2 was 10 Gy, T3 was 17  Gy and for T4 the mean was 26  Gy. 
 
Theon et al.’s (1995) study showed the total median control was seventeen months 
and the mean 28 months (see Table 1.4 on page 27) and that the larger tumours 
adversely affected the results of the treatment. The aforementioned study showed 
the most beneficial results of all the studies examined. In contrast to Theon et al. 
(1995) study, the present study used a much lower dose of radiation for all the 
different tumour grades but was as successful except for T4.  
 
The results being compared are as follows: 
(a)  In the current study, the survival results at two years are; T1=75% but it 
should be noted that the four cats (25%) that died in this group during this 
period died of non-related causes. The group T2 had a 60% survival but once 
again four cats (27%) died of non-related causes. See Table 3.5 on page 50 for 
the cats that survived after the two year period. In the study by Theon et al. 
(1995) T1 had a result of 84% at twelve months and T2 58% at 60 months. The 
present study compares very well with Theon’s study at the early levels. 
(b)  At the higher grade of tumour T3, as reported by Theon et al. (1995) none 
of the cats survived the five year study period. But the progression survival 
rate at one year for T3 was 46% with a median of nine months. In the current 
study at two years, T3 had a median survival of 17 months. In this group the 
median survival in this study was eight months more than the orthovoltage 
study even though the total radiation dose was considerably less (17 Gy) and 
(40  Gy). 
(c)  At Grade T4  Theon et al.(1995) had a progression free survival rate of 
51% with a median of 22 months at one year. This result is surprising bearing 
in mind that there was only a 9 month median survival for his T3 group using a 
total of 40 Gy. The present study showed that at a two year survival the median 
for T4 was only six months. Theon’s result in the T4 group was apparently 
very much better than in this study. 
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 It is clear that the T3 and T4 tumours in the  present study, with their large tumour 
volume needed a higher total dose of radiation than 26 Gy and maybe even more 
than the 40 Gy used by Theon et al.(1995). However the toxic radiation dose for 
nasal planum tissue has not yet been established which makes increasing the 
radiation dose easier said than done. 
 
Comparison between the study by Theon et al. (1995) and this study is complex but 
an overall judgement is that both studies show that radiation therapy is a more 
successful treatment than the other modalities.  
 
At the time of this study orthovoltage radiation was generally not available for 
veterinary patients in South Africa. 
ii) Cobalt Mega voltage radiation  
Prof. S. Lana, (2002) (personal communication) a veterinary oncologist at 
Colorado State University USA, is of the opinion that radiation is certainly a 
good tool for non- resectable disease but is costly and time-consuming. This 
statement of Prof. S. Lana is correct, if a total dose of 49 Gy has to be 
administered. But if the patients are referred at an early stage and a total 
dose of 10 Gy is needed, radiation would become a more cost effective and 
less time-consuming form of treatment. 
iii) Strontium radiation  
Van Vecheten and Theon (1993) in their study described the results of the 
treatment of twenty-five cats, all with well-differentiated lesions. The 
irradiation was done with a strontium ophthalmic applicator. This gave a 
200 Gy surface dose (2 mm depth) and was given as a single dose. The 
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effects on the well-differentiated tumours were similar to the results 
achieved by using ortho-voltage and mega-voltage radiation.  
 
This therapy is only suitable for superficial lesions. If these machines are 
readily available for use by veterinarians, the convenience of using only one 
treatment makes this method effective and probably relatively inexpensive. 
This further emphasizes the need for early diagnosis and treatment. 
4.3   THE STATISTICAL ANALYSIS OF THE DATA OF THIS STUDY 
Bear in mind that as already stated, statistically these are small sample sizes. 
However in comparing the results to the other visually graded squamous cell 
carcinoma tumour studies Magne et al. (1997) and Theon et al. (1995) similarities 
do occur with the visual grading, radiation doses and the consequent results. 
 
4.3.1   The ratio of male to female cats  
In the current study this variable showed no statistically significant effect 
on the rate of survival. Overall there were 18% more females than males in 
the study. All the cats in the study had been sterilized. The comparable 
studies did not report on results relating to the different sexes. 
 
4.3.2   The age and tumour levels of the patients  
In the present study the variable for age showed no statistically significant effect 
on the rate of survival. The total range of the affected cats was between 3-23 
years, which is large. The mean age for the tumour levels is T1=10.1 y, T2 =10.4 
y, T3=10.4 y and T4=12.8 y. 
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 The median age for the total number of cats was 10 years and the mean 10.96 
years. This shows good correlation. It was worrying to see that the mean age of 
grade T1 was 10.8 years and yet the range was 4 to 18 years. This disease has 
clinically always been regarded as a disease of old cats. To find the range 
included cats as young as four years old being diagnosed with squamous cell 
carcinoma of the nasal planum is important as it means that early prevention and 
recognition of the disease becomes imperative.    
 
In group T4 there was once again a 3 year old cat. The mean age of the group 
was one year older than the total mean. Statistically this does not have any 
significance. However, it might be explained by the fact that the owners had 
ignored the early symptoms or just accepted that their older cats had a non-
treatable disease, or that the veterinarians had been trying to treat the lesion 
unsuccessfully with a variety of treatments.  
 
The age of the cat when presented for radiation treatment is of no 
importance as cats of twelve years and older with grades T2 and T3 
tumours were successfully treated. Previous authors have not correlated 
age, tumour grade and treatment outcome. 
 
4.3.3 Comparison of the mean radiation dose  required for the  
            treatment of the different grades of tumour 
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Although the mean total radiation dose (Gy) per grade was not statistically 
significant for survival, using Cox regression, a trend did appear. It showed 
that the higher the tumour grade, the more radiation was needed to have a 
therapeutic effect on the tumour. Although this fact might have been 
expected, the reality is that the other studies using radiation, Theon et al. 
(1995) and Lana et al. (1997), used a uniform dose of 40  Gy and 49  Gy 
respectively for all tumours regardless of size and aggression. 
 
During the present series none of the cats showed any discomfort or pain during 
the radiation therapy. There was a loss of hair, with the cats having a high total 
radiation treatment, with regrowth over 2 month period, but there was still no 
evidence of pain or discomfort. This is in contrast to Theon (1995) who used 
higher doses and reported skin and membrane lesions. None of the cats treated 
suffered any signs of skin radiation toxicity, acute or late, and there were no 
adverse effects due to the anaesthetic agent. These reduced side effects may well 
be due to use of megavoltage radiation in contrast to orthovoltage radiation. 
 
An example of a cat being treated with a high radiation dose (total 76 Gy) 
in 3 Gy fractions is recorded in Figure 4.3. In this case the owner/cat bond 
was extremely strong and the owner refused to take the euthanasia option 
which her veterinarians thought to be the kindest route. The owner 
understood that the treatment would be palliative and only if there was 
really good progress would the treatment be continued.  As can be seen the 
patient did respond and lived for a further nine months free of tumour pain, 
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able to breathe and eat easily. The patient was euthanased due to chronic 
kidney failure and the visible signs of squamous cell carcinoma recurrence. 
 
       
(a)  at presentation                                                 (b) Three months after radiation  
 
Figure 4.3: Palliative treatment for 18 year old cat  
 
4.4   ENVIRONMENTAL CONTROL OF EXCESSIVE UVB EXPOSURE 
Finally, although most studies mentioned that the cause of the squamous cell 
carcinoma was high UVB exposure, none of the authors of the articles showed 
much concern with changing the behaviour and environment to protect the 
vulnerable cat. In this study when the cost of the treatment for T1 and T2  
tumours was R225.00 and R300.00, respectively and the cost for  T3 and T4 
tumours was R375.00 and R625.00, only one client could be persuaded to 
institute good effective environmental control. It is interesting to observe that 
now that the costs have risen from R225.00 to R1155.00 to treat a grade T 1 
tumour and from R625.00 to R3465.00 for a grade T 4 tumour, approximately 
45% of owners are willing to comply with environmental control. These cats are 
currently being monitored to try and prove the efficacy of this control. A further 
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factor in the change of attitude of the owners is the heightened awareness of the 
public to the devastating effects of global warming and increased UVB exposure. 
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CHAPTER FIVE  
CONCLUSION 
 
As explained in the introduction, the etiology of the nasal planum squamous cell 
carcinoma is simply, excessive exposure to the B fraction of ultraviolet radiation 
and the tissues’ response to the solar radiation. Although there is now a general 
awareness of the effect of global warming, there is no hope that in the near future, 
a thick, protective blanket of ozone will surround the world. Likewise there is 
little hope that people will stop breeding cats with non-pigmented nasal planums, 
so where do we go from here? Practical solutions have to be sought. 
 
Recognition of the condition and the various treatments are well recorded. This 
present study is a refinement of earlier work with radiation and has shown that 
mega-voltage radiation can play a most effective part in the treatment of actinic 
induced squamous cell carcinoma of the nasal planum. 
 
In summary this study showed that at two years, different radiation doses used as 
a survival therapy for the four visually graded levels were very effective at the 
tumour levels T1 and T2.  The treatment was fairly successful at T3 level and 
only palliative at the T4 level. Initial visual grading of the tumours was 
statistically highly significant on the survival rate. The age, sex, number of 
treatments, and the total radiation dose of the patient had no significant effect on 
the rate of survival using Cox’s regression analysis. This means that radiation 
therapy must be implemented at the earliest opportunity. 
 78
The two most difficult challenges for the future are firstly, to educate the 
veterinarians and the owners to recognise the disease at an early stage and 
secondly, to obtain access to radiation machines. 
 
It is essential that veterinarians and undergraduates are educated as to the advantage of 
radiation as an effective treatment for feline nasal planum. This can be by means of 
congresses, journal articles, web pages, posters, leaflets and informal talks. The owners 
also have to be informed so that they are aware of the problem and can bring it to the 
veterinarians’ notice at an early stage. This knowledge can be imparted through the 
media e.g. pet magazines, together with radio and television programmes and 
information supplied by the veterinarians in their waiting rooms. 
 
As part of this study an Internet search was carried out to ascertain the accessibility of 
mega voltage radiation facilities to veterinarians for their patients. This search showed 
that there are two facilities in the United Kingdom, Cambridge University and a private 
facility in Newmarket. In the United States of America there are forty facilities of 
which twenty are supported by universities. Canada has a unit attached to the veterinary 
school and Australia has two units offering radiation therapy. No other countries 
offering radiation therapy for companion animals could be found. For the many 
countries that do not have radiation facilities for companion animals the first prize will 
be early recognition of the tumour and treatment that is available e.g. surgery and 
cryotherapy with additional environmental control. 
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In South Africa the Medical School of the University of the Witwatersrand has a 
cobalt60 machine used for animal research that was available for treating dogs and cats. 
Unfortunately, after this study was completed, the cobalt source was depleted and the 
university was unable to finance a new source. Fortunately one of the seventeen 
privately owned mega-voltage radiation facilities in South Africa allowed the use of 
their linear accelerator for animal radiation outside normal working hours. 
 
Prohibitively high capital and maintenance costs preclude the use of these machines in 
dedicated veterinary hospitals in South Africa. Only if veterinarians are permitted the use 
of human facilities will they be able to treat, not only the nasal planum squamous cell 
tumours but also the other numerous radiosensitive cancers diagnosed in cats and dogs. 
 
Of prime importance with the radiation treatment is the relief of the cats’ pain, usually 
after only two or three treatments. Cats that have been in varying degrees of discomfort 
begin to respond by eating, grooming, playing and mousing. The owners’ joy and the 
veterinarians’ relief at not having to euthanase yet another cat suffering from this 
destructive tumour brings a realisation of how successful mega-voltage  radiation 
treatment is, despite the time consuming treatments and their expense. 
 
As global warming intensifies and the protective ozone layer diminishes the prevalence 
of solar induced squamous cell carcinomas will undoubtedly increase. For those areas 
having a high incidence of feline nasal planum squamous cell carcinoma, a highly 
desirable situation would be early recognition, visual classification of the tumour and a 
successful treatment regime.  
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 This study together with the studies undertaken by Theon et al.(1995) and Magne et al. 
(1997), had good correlation with the grading on visualisation into four groups (least to 
worst) when the results were compared. Although many different treatments have been 
tried, the most successful results appear to be radiation of these tumours. Future work 
should focus on devising a radiation protocol that will achieve the optimal success for 
each different grade of nasal planum squamous cell carcinoma. 
  
This study has shown that the most practical non invasive solution to squamous 
cell carcinoma of the nasal planum of cats in the early stages is mega-voltage 
radiation therapy. 
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APPENDIX A 
 
University of the Witwatersrand, Johannesburg  
 7 York Rd, Parktown  
  2195 South Africa  
  Tel. (011) 647-1111  
 
INFORMED CONSENT TO TREATMENT 
  
1. I, the undersigned, hereby authorise the veterinarian and staff of the above 
animal hospital to perform any reasonable treatment, anaesthesia, radiation and 
surgery they may deem necessary, including and or further or alternative 
measures as maybe necessary during the course of the Cobalt 60 radiation 
treatment of my animal. 
2. I undertake to keep in daily contact between 9-10am to enable the staff to 
inform me of the progress, costs incurred and additional treatment involved. 
3. I confirm that I am aware of the extent and approximate costs involved, and 
that I will pay COD on collection of my animal for my animal after each 
treatment.  
4. I acknowledge that I am indebted to the above practice for veterinary 
treatment, services rendered and expenses incurred therewith and hereby 
render myself responsible for all costs. 
5. I confirm that my animal has a valid vaccination certificate i.e. vaccinated 
during the previous twelve months. 
6. My cat/dog will be brought to the facility in a basket or on a lead. 
 
 Name of Owner (person responsible for the account) 
……………………………………………………………………… 
Residential 
address……………………………………………………………… 
……………………………………………………………………… 
E-mail 
address…………………………………………………………………
…………………... 
Telephone number: 
Home ………………Work…………………Cell ………………….. 
Signature 
…………………………………………………………….Date…… 
APPENDIX B 
CLINICAL DATA SHEET FOR RADIATIONPATIENT 
DOG/CAT  
NAME of 
PET………………………………………………………………… 
Species……………………….Breed……………………………………
………………………… 
Sex…………………………….Age…………………Weight…………
………………………… 
Referring 
Veterinarian……….Dr……………………………………………… 
Practice……………………………………………………………… 
Telephone……………………..Email……………………………… 
Diagnosis from referring 
veterinarian…………………………………………………………….
…………………………………………………………………… 
Location……………………………………………………… 
Date of relevant history (first noticed, operations etc) 
1…………………………………………………………………………
………………………….. 
2…………………………………………………………………………
………………………….. 
3…………………………………………………………………………
………………………….. 
4…………………………………………………………………………
………………………….. 
5………………………………………………………………… 
Signature …………………………………Date 
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